BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE
Clinical trials for BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE explained in plain language.
Never miss a new study
Get alerted when new BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE trials appear
Sign up with your email to follow new studies for BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan could pinpoint returning prostate cancer
Diagnosis CompletedThis Phase 3 study tested a radioactive tracer called Copper Cu 64 PSMA I&T, given as an injection, to improve PET/CT scans in 235 men with prostate cancer that may have returned after initial treatment (surgery or radiation). The goal was to see how accurately the scan could det…
Matched conditions: BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE
Phase: PHASE3 • Sponsor: Curium US LLC • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
New PET scan agent spots prostate cancer missed by standard tests
Diagnosis CompletedThis phase 2 study tested a new radioactive imaging agent called 64Cu-SAR-BBN in 53 men with prostate cancer that had returned after treatment but was not visible on standard PSMA PET scans. The goal was to see if this agent could safely and accurately detect where the cancer had…
Matched conditions: BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE
Phase: PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC